Lisa Dalton

Insider Reports History

Entity
Individual
Location
3737 Market Street, Suite 1300, Philadelphia, PA
Signature
/s/ J. Christopher Naftzger, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lisa Dalton:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nabriva Therapeutics plc Director Ordinary Shares 9.1K $13.7K $1.50 Jul 31, 2022 Direct

Insider Reports Filed by Lisa Dalton

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NBRV Nabriva Therapeutics plc Jul 31, 2022 1 -$1.5K 4 Aug 3, 2022 Director
NBRV Nabriva Therapeutics plc Jul 28, 2021 2 $0 4 Jul 30, 2021 Director
NBRV Nabriva Therapeutics plc Jun 2, 2021 1 $0 4 Jun 4, 2021 Director
NBRV Nabriva Therapeutics plc Jun 2, 2021 0 $0 3 Jun 4, 2021 Director